"10.1371_journal.pone.0037269","plos one","2012-06-05T00:00:00Z","Aase B Mikalsen; Oyvind Haugland; Marit Rode; Inge Tom Solbakk; Oystein Evensen","Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, Oslo, Norway; PHARMAQ AS, Oslo, Norway","Conceived and designed the experiments: ABM MR OE. Performed the experiments: ABM ITS MR OH OE. Analyzed the data: ABM OH MR OE. Contributed reagents/materials/analysis tools: ITS ABM MR OH OE. Wrote the paper: ABM OE.","The authors have the following conflicts: Dr. Rode and Dr. Solbakk have ownership in PHARMAQ. Dr. Evensen received funding from the Research Council of Norway. Dr. Evensen has been acting as expert witness and as consultant for PHARMAQ. Dr. Mikalsen and Dr. Haugland declare no competing interests. PHARMAQ holds a patent entitled Heart and skeletal muscle inflammation (HSMI) virus in UK and a exclusive license on the use of the GF-1 cell line. There are no products against HSMI licensed in any markets. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, apart from the GF-1 cell line being for exclusive use in PHARMAQ.","2012","06","Aase B Mikalsen","ABM",5,FALSE,3,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
